Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) insider Corrine Savill sold 40,000 shares of the firm’s stock in a transaction dated Monday, January 29th. The shares were sold at an average price of $14.09, for a total transaction of $563,600.00. Following the transaction, the insider now directly owns 165,990 shares in the company, valued […]